bupropion hydrochloride
- Product NDC
- 69844-065
- 11-digit product format
- 698440065
- Labeler code
- 69844
- Product ID
- 69844-065_252da699-f39a-4df8-83af-b6c0a1d90426
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- extended-release
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA211020
- Marketing category
- ANDA
- Marketing start
- 2019-01-28
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-065-01 | 69844006501 | 30 TABLET in 1 BOTTLE (69844-065-01) | 30 tablet | 2019-01-28 | 0000-00-00 | No | No | Current |
| 69844-065-02 | 69844006502 | 90 TABLET in 1 BOTTLE (69844-065-02) | 90 tablet | 2019-01-28 | 0000-00-00 | No | No | Current |
| 69844-065-03 | 69844006503 | 1000 TABLET in 1 BOTTLE (69844-065-03) | 1000 tablet | 2019-01-28 | 0000-00-00 | No | No | Current |
| 69844-065-04 | 69844006504 | 500 TABLET in 1 BOTTLE (69844-065-04) | 500 tablet | 2019-01-28 | 0000-00-00 | No | No | Current |